The Conservative government has defeated a bill designed to amend the Access to Medicines Regime that allows for enhanced access to generic pharmaceuticals in the developing world. Despite the fact that other countries are doing far more to support access, Industry Minister Christian Paradis claimed the bill would violate WIPO standards.
Conservatives Defeat Bill Promoting Developing World Access to Generic Drugs
November 29, 2012
Share this post
2 Comments

Law Bytes
Ep. 265 – Jason Millar on Claude Mythos, Project Glasswing, and the Governance Crisis in Frontier AI
byMichael Geist

Ep. 265 – Jason Millar on Claude Mythos, Project Glasswing, and the Governance Crisis in Frontier AI
April 20, 2026
Michael Geist
March 30, 2026
Michael Geist
March 16, 2026
Michael Geist
Search Results placeholder
Michael Geist on Substack
Recent Posts
Lawful Access Heads to Committee: The Opposition Found Its Voice, the Government Never Found Its Defence
Is Data De-Identification Dead?: Why the AI Privacy Risk Isn’t What It Learns, But What It Figures Out
The Law Bytes Podcast, Episode 265: Jason Millar on Claude Mythos, Project Glasswing, and the Governance Crisis in Frontier AI
A Standard That Doesn’t Exist: Parliamentary Secretary for Justice Offers Misleading Defence of Bill C-22’s Lower Threshold for Subscriber Information
More Surveillance Demands to Come?: Government Admits Bill C-22’s Lawful Access Provisions Could Be Expanded

Missing word
Presumably “other countries are doing far to” should be “other countries are doing far *more* to”
Where would we be, if not for those WIPO standards…